Comparison of three different risk-stratification models for predicting lymph node involvement in endometrioid endometrial cancer clinically confined to the uterus

Vakkas KORKMAZ; Mehmet-Mutlu MEYDANLI; Ibrahim YALÇIN; Mustafa-Erkan SARI; Hanifi SAHIN; Eda KOCAMAN; Ali HABERAL; Polat DURSUN; Tayfun GÜNGÖR; Ali AYHAN.
Journal of Gynecologic Oncology ; : e78-2017.
Artículo en Inglés | WPRIM | ID: wpr-61128

Documentos relacionados

  1. Is microcystic, elongated, and fragmented pattern of myometrial invasion in endometrioid endometrial carcinoma associated with survival?
  2. Predictability of lymph node involvement in uterus-confined endometrioid endometrial cancer by tumour size, pattern and location measured with transvaginal ultrasonography: can we save time?
  3. [Clinical application of TCGA molecular classification in endometrial endometrioid carcinoma].
  4. Tumor diameter as a predictor of lymph node involvement in endometrioid type endometrial adenocarcinomas.
  5. Clinical impact of genetic alterations of CTNNB1 in patients with grade 3 endometrial endometrioid carcinoma.
  6. Genomic landscape of endometrial carcinomas of no specific molecular profile.
  7. The amount of preoperative endometrial tissue surface in relation to final endometrial cancer classification.
  8. Metastatic endometrioid carcinoma in a hybrid Leontopithecus sp.
  9. Mixed clear cell/endometrioid and clear cell/serous carcinoma of the uterus are clinicopathologically similar to pure clear cell carcinoma: An NRG Oncology/Gynecologic Oncology Group (GOG-210) study of 311 women.
  10. Endometrioid adenocarcinoma arising in adenomyosis in a patient with pelvic organ prolapse-case report.